Akron Children's Logo
Skip to main content
Close Tools Menu Icon

Operator:

330-543-1000

Questions or Referrals:
ASK CHILDREN‘S

Close Phone Menu Icon
Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Tretinoin and Arsenic Trioxide in Patients With Untreated Acute PML

Full IRB Study Title:
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-trans Retinoic Acid

IRB Study ID: 1099169

For complete information, please visit the study on clinicaltrials.gov

Study Sponsor:

Children's Oncology Group

Back to top of page

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.